killed and vanishing!
Five holistic health doctors including Doctor James Jeffrey Bradstreet, have been reported as being found dead in the past four weeks and five more have gone missing – after alleged encounters with Feds which was probably the FDA. These reports need further verification.
Test for monitoring efficacy of therapy for cancer and certain viral infections
Nagalase in serum / plasma
The test measures the activity of an enzyme α-N-acetylgalactosaminidase (nagalase) in blood.
Nagalase is an extracellular matrix-degrading enzyme that is secreted by cancerous cells in the process of tumor invasion. It is also an intrinsic component of the envelope protein of various virions, such as HIV and the influenza virus. Thus, it is also secreted from virus-infected cells1,3,4.
Nagalase deglycosylates the vitamin D3-binding protein DBP (also known as Gc-protein). Gc-protein, which contains three sugars, is the precursor for the major macrophage-activating factor (MAF). By complete deglycosylation, Gc-protein can no longer be converted to MAF.
Normally, MAF is produced from the Gc-protein by sequential removal of the galactose and sialic acid without touching the remaining sugar N-acetylgalactosamine.
Macrophage activation for phagocytosis and antigen presentation is the first step in the immune development cascade. Lost precursor activity, therefore, leads to immune suppression.
Increased nagalase activity has been detected in the blood of patients with a wide variety of cancers like cancer of the prostate, breast, colon, lung, esophagus, stomach, liver, pancreas, kidney, bladder, testis, uterus, and ovary, mesothelioma, melanoma, fibrosarcoma, glioblastoma, neuroblastoma, and various leukemias1,3,4. For various types of tumors, various levels of nagalase activity were found7. It appears that the secretory capacity of individual tumor tissue varies among tumor types depending upon tumor size, staging, and the degree of malignancy or invasiveness7. Increased nagalase activity has not been detected in the blood of healthy individuals1.
Nagalase activity is directly proportional to viable tumor burden1,2. Studies correlating nagalase levels with tumor burden suggest that the measurement of this enzyme can diagnose the presence of cancerous lesions below levels detectable by other diagnostic means1. In research studies, nagalase activity decreased to near tumor-free control levels one day after surgical removal of primary tumors from cancer patients, suggesting that the half-life of nagalase is less than 24 hours1,6. The short half-life of nagalase is valuable for prognosis of the disease during various therapies1,5.
GcMAF for the treatment of cancer, autism, inflammation, viral and bacterial disease
by David Noakes
Human GcMAF, otherwise known as Vitamin D binding protein macrophage activating factor, holds great promise in the treatment of various illnesses including cancer, autism, chronic fatigue and possibly Parkinson’s. Since 1990, 59 research papers have been published on GcMAF, 20 of these pertaining to the treatment of cancer. 46 of these papers can be accessed through the GcMAF web site.
GcMAF is a vital part of our immune system which does not work without it; and is part of our blood. GcMAF stimulates the macrophage element of the immune system to destroy cancer cells. It also blocks the supply of nutrients to cancer cells by stopping blood vessel development to the site (anti-angiogenesis). Cancer cells are weakened and starved, making them more vulnerable to attack by the GcMAF stimulated macrophage system. Research has shown macrophage activation and stopping diseased blood vessel development can also help in various neurological diseases such as Parkinson’s, Alzheimer’s, rheumatoid arthritis, inflammatory conditions, and diabetic retinopathy.
In the case of autism, Dr. James Bradstreet has so far treated 1,100 patients with GcMAF with an 85% response rate. His results show a bell curve response with 15% of the patients showing total eradication of symptoms and 15% showing no response.
In addition, experimental and clinical evidence confirms that GcMAF shows multiple powerful anti-cancer effects that have significant therapeutical impact on most tumors including breast, prostate, and kidney. GcMAF is created in the body by the release of two sugar molecules from a GcProtein molecule.
However, tumors release an enzyme known as Nagalase. Nagalase degrades GcProtein to the point it is unable to become GcMAF. Since GcMAF only lives for about a week in the body, without continuous conversion of GcProtein the stores of GcMAF are depleted rapidly in the presence of Nagalase. However, Nagalase can only destroy GcProtein and not GcMAF. Thus the introduction of external GcMAF through injection into the body has been shown to be effective.
GcMAF has no side effects of its own, but in under 10% of cases the immune system, which will be rebuilt in just three weeks, can produce considerable side effects in autistic children. The treatment consists of an injection with a tiny diabetic sized syringe once a week. The duration depends on the severity of the disease. Research also reveals that in cancer cases that are stage I and II, the success rate approaches 90% inside 6 months. Nagalase and immune system levels can be measured in the blood and thus offer a marker for cancer and other diseases.
In conclusion, GcMAF restores the energetic balance in the cell. Cancer cells driven by sugar metabolism become healthy oxygen driven cells, so tumor cells no longer behave as parasitic organisms. GcMAF stimulates macrophages to consume the cancer cells and cells invaded by viruses. This stimulation of the immune system and the anti-angiogenetic effect surrounding the tumor is beneficial in cancer and several neurological disorders like autism, chronic fatigue, Parkinson’s, and Alzheimer’s, and it is available to the general public.
The following testimonials are from the gcmaf.eu web site:
Hello Dr. Bradstreet, After 13 weeks of the GCMAF, we are happy to report that she continues to have tremendous gains in all areas. Increased socialization and speech, better performance in the school as well as community settings, decreased tantrums and less vocal protests, she is able to change activities and transition to non preferred tasks. It has been absolutely amazing, all her therapists, teachers, other parents have remarked about her good behavior in public places (for example, grocery stores, department stores such as Nordstrom’s, Macy’s, The Zoo, Bowling, the library, parks and playgrounds. In the past, we never went to these places in fear of her stimming, or her behavior (45 minute tantrums). Now, she surprises us as well as others with her appropriate comments and follows direction very well. Before she would only eat one thing (french fries) and now she eats everything including vegetables!!!!! I’ve sent some pictures to show her progress. We are so excited to see what more phenomenal things are in the future to come!
Ovarian and lung cancer
I first contracted cancer in the form of a granulosa cell tumour in 2005. After 2 operations and 3 months of chemo by January 2010 it had reached stage 4 and had spread from my ovaries to my lungs. After that scan in January I was told the chemo had failed, my 5 tumours were still growing, given Tamoxifen hormone, told I had between 3 months and 2 years left to live, and sent on my way.
I started taking GcMAF at the age of 56 on 16th May 2010; the only feeling or side effect I have from GcMAF is I felt almost from the beginning that I had my old energy back and was feeling much better and fitter in myself. After 8 weeks of taking only GcMAF and Tamoxifen I went for a scan. This showed all tumours had shrunk, the four in my lungs were now hardly noticeable and that the aggressive tumour in my pelvis had shrunk from 7.4cm to 4.1 cm. This is a significant decrease in size.
The stand-in consultant was very excited, and said these were excellent results. As I did not know her, and she did not ask, I did not tell her why.
On the 21st Oct I had another scan; the improvements continued; the secondaries appeared to be merely scar tissue, and the pelvic tumour had shrunk to 3.5 cm
In the winter my improvements seemed much slower; we now know because GcMAF needs normal vitamin D levels. But I’ve just got back from a wild month in Australia and Thailand, the sunshine should have done wonders for my vitamin D levels, and for my next scan. I will keep you updated. But I am over the moon and feel better than ever. And yes, you can phone me if you like. Gail in London.
“I have the opportunity to treat patients from all over the World and the addition of GcMAF for my cancer patients is truly adding a new dimension not previously available to us. Recently I have been following a 42 year old women who had already undergone surgery, radiation and chemotherapy for stage IIIB breast cancer. I obtained a nagalase test through ELN (Holland) and it returned in the very elevated range of 4.20nmol/min/mg (normal reported by this lab does not exceed 0.95). Her other tumor markers were not elevated, but her PET scan demonstrated a likely metastatic site in the hip bone.
After discussing her options the patient wanted to try GcMAF therapy prior to considering more radiation or chemotherapy. After 6 weeks of GcMAF 100ng/week subcutaneous injections (much like a shot of insulin) her repeat nagalase test returned at 2.10 (a 50% reduction). All of her other tumor markers remain negative and she is taking the dose of Vitamin D3 required to optimize her blood levels (9000 iu/day). It is too soon for her PET to be repeated but we will follow this soon to determine the course of the bone metastasis. The nagalase test may be a more sensitive marker for tumor burden than other more accepted blood tests. GcMAF given via simple patient administered once weekly injections is clearly able to reduce the nagalase level dramatically over a short period of time. In previous published studies, nagalase response to GcMAF was correlated with reduction and eventual elimination of cancer. This is an encouragement to us all and I will keep you posted on the patient’s progress.”
For more information please visit First Immune GcMAF or contact David Noakes at:
First Immune GcMAF
Clos de Balade 21
This article appeared
at The Washington Post
Anti-vaccine doctor behind ‘dangerous’ autism therapy found dead. Family cries foul.
June 29, 2015
James Jeffrey Bradstreet’s life was full of controversy. To thousands of supporters, he was a savior: a physician who claimed vaccines caused autism and promoted radical procedures to treat those afflicted, including his own son.
To many others, however, he was a crackpot: a man who, despite his medical license, ignored science and championed dangerous, discredited and occasionally deadly treatments. [Washington Times spin.]
It’s no surprise, therefore, that Bradstreet’s death is proving equally divisive.
On the afternoon of June 19, a fisherman spotted Bradstreet’s lifeless body lying in the Broad River in the tiny town of Chimney Rock, N.C. He had a gunshot wound to his chest, authorities said. A gun was found in the water nearby.
That’s about all that everyone can agree on.
Like his research, Bradstreet’s death has become a Rorschach test in which his supporters see a conspiracy, while most everyone else — including law enforcement — sees a slow downward slide towards suicide.
The Rutherford County Sheriff’s Office said it is investigating Bradstreet’s death, but that the wound appears to have been self-inflicted. [More spin. Conjecture, but would a man with this amount of dedication and determination investigating the cause of autism up against the frighteningly powerful pharmaceutical corporations which so many people depending on his work commit suicide?]
Bradstreet’s family, however, has set up an online account to raise funds for “an exhaustive investigation into the possibility of foul play.”
“Jeff dedicated his life’s work to finding answers, always pushing the envelope, and never giving up, even at the risk of being perceived as controversial,” wrote his niece, Cali Bradstreet Howell, on the gofundme Web site. “Now, in this moment, we find ourselves in a position, where we too are in search for answers … and we intend on finding them.”
[Disneyland measles outbreak strikes in anti-vaccination hotbed of California] [Was this incident made to happen based on the individuals and their backgrounds and where they came from (were they immigrants?) just before California made the decision to make vaccinations mandatory.]
Bradstreet had been a leading voice in the anti-vaccine, or “anti-vaxxer,” movement for nearly two decades.
He was a former preacher who traded the pulpit for a physician’s gown, according to the Gwinnett Daily Post. Bradstreet received his medical degree from the University of South Florida and completed his residency at the Wilford Hall USAF Medical Center in Texas, according to a paper he wrote.
Please go to the Washington Times web site to read the entire article on Doctor James Jeffrey Bradstreet’s death.
This information appeared
at Age of Autism
Dr. Bradstreet, Nagalase, and the Viral Issue in Autism
By Kent Heckenlively, Esq.
Although my daughter is not a patient of Dr. Jeff Bradstreet I’ve always had an enormous amount of respect for the good doctor. I’ll usually go on his website once or twice a month to find out what has most recently attracted his interest. Often it seems we’re looking at similar questions; which either means great minds think alike, or we suffer from some of the same delusions.
I was intrigued by his October 11, 2011 entry, “An Update on Viral Issue in Autism” since it dovetailed with some of my own recent investigations.
In the past months, Dr. Bradstreet has become interested in nagalese, which he describes as an enzyme “produced by cancer cells and viruses.” He thinks it unlikely that children with autism have undiagnosed cancers, and thus suspicion falls on a viral etiology. Dr. Bradstreet writes, “Viruses make the nagalese enzyme as part of their attachment proteins. It serves to get the virus into the cell and also decreases the body’s immune reaction to the virus-thereby increasing the odds of viral survival.”
Further on Dr. Bradstreet writes, “It is reasonable and likely that the nature of the immune dysfunction and the frequently observed autoimmune problems in autism are mediated by persistent, unresolved viral infections.” He claims to have tested approximately 400 children with autism for the viral marker, nagalese, and found that nearly 80% have significantly elevated levels. He hopes to publish soon on this study and believes this information “is one of the most important developments in the clinical treatment of children on the spectrum that I have experienced in the last 15 years.”
Dr. Bradstreet’s article got my attention because of my daughter’s own nagalese testing. I had her tested back in May (when she’d endured three hospitalizations due to uncontrolled seizures) and her reading was 3.3 (reference range 0.35-0.95). In desparation we tried the ketogenic diet (high fats and low carbs), and although there have been some rough patches since May we have avoided further hospitalizations.
And her stools normalized.
Yes, I know all of you realize how important that is. We’re talking months and months of good stools. Seizures down at least 80%. So of course, your friendly neighborhood science teacher was interested in what her nagalese levels might be, so we did a retest in late September. This time her reading was 1.7. It was about a 50% drop, and while it’s still abnormal, it is progress. It makes me wonder if a low-carb diet starves viruses of an energy source.
There are critics of nagalese testing. Dr. Enlander, a specialist in chronic fatigue syndrome/ME, another disease which may be viral in origin, doesn’t believe the tests are sensitive enough to be of any value. And he may be right.
Dr. Bradstreet also discusses a substance called GcMAF, which I don’t have enough information about to make an informed judgment, and that after viral clearance, the possibility of using neuronal stem cells which can cross the blood-brain barrier. I really can’t comment on the advisability of either suggestion.
But if you are like me, still looking for that clue which might help your child join the ranks of the recovered, you might investigate nagalese.
Kent Heceknlively is a Contributing Editor to Age of Autism